Gambaran Umum
Entheon Biomedical Corp. is a biotechnology company based in Canada, primarily focused on developing psychedelic-based therapies to address addiction disorders. The company is leveraging advanced scientific and medical research to create treatments that target the brain mechanisms responsible for addictive behaviors. Entheon's key project involves the clinical development of DMT (N,N-Dimethyltryptamine) as a potential therapeutic tool. This initiative involves comprehensive clinical trials designed to test the safety and efficacy of DMT in treating addiction, aiming to provide a new and effective option for patients suffering from these conditions. Through this innovative approach, Entheon Biomedical Corp. seeks to revolutionize the treatment landscape for addiction, offering hope and new solutions for recovery.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Entheon Biomedical Corp. per 2025 May 31 adalah -0.37 MM.
- Nilai net income untuk Entheon Biomedical Corp. per 2025 May 31 adalah -0.36 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-05-31 | -0.37 | -0.36 | |
| 2025-02-28 | -0.40 | -0.39 | |
| 2024-11-30 | -0.33 | -0.32 | |
| 2024-08-31 | 0.00 | -0.32 | -0.31 |
| 2024-05-31 | 0.00 | -0.35 | -0.34 |
| 2024-02-29 | 0.13 | -0.28 | -0.28 |
| 2023-11-30 | 0.25 | -0.31 | -0.30 |
| 2023-08-31 | 0.37 | -0.47 | -6.07 |
| 2023-05-31 | 0.44 | -1.04 | -5.51 |
| 2023-02-28 | 0.31 | -2.19 | -6.75 |
| 2022-11-30 | 0.19 | -3.60 | -8.52 |
| 2022-08-31 | 0.06 | -4.58 | -4.55 |
| 2022-05-31 | -0.00 | -5.66 | -6.73 |
| 2022-02-28 | -6.57 | -7.87 | |
| 2021-11-30 | -8.21 | -8.89 | |
| 2021-08-31 | 0.01 | -7.52 | -10.31 |
| 2021-05-31 | 0.00 | -6.19 | -8.94 |
| 2021-02-28 | -4.46 | -6.90 | |
| 2020-11-30 | -1.64 | -4.38 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-05-31 | ||
| 2025-02-28 | ||
| 2024-11-30 | ||
| 2024-08-31 | -0.04 | -0.04 |
| 2024-05-31 | ||
| 2024-02-29 | -0.05 | -0.05 |
| 2023-11-30 | -0.05 | |
| 2023-08-31 | -1.03 | -1.03 |
| 2023-05-31 | -0.93 | -0.93 |
| 2023-02-28 | -1.14 | -1.16 |
| 2022-11-30 | -1.44 | |
| 2022-08-31 | -0.77 | -0.77 |
| 2022-05-31 | -1.15 | -1.15 |
| 2022-02-28 | -1.38 | -1.36 |
| 2021-11-30 | -1.60 | |
| 2021-08-31 | -2.16 | -2.16 |
| 2021-05-31 | -2.17 | -2.17 |
| 2021-02-28 | -2.04 | -2.02 |
| 2020-11-30 | -1.60 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Entheon Biomedical Corp. per 2025 May 31 adalah -0.39 MM.
- Nilai kas dari aktivitas pendanaan untuk Entheon Biomedical Corp. per 2025 May 31 adalah 0.50 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-05-31 | -0.39 | 0.50 | |
| 2025-02-28 | -0.37 | 0.65 | |
| 2024-11-30 | -0.36 | 0.15 | |
| 2024-08-31 | -0.31 | 0.01 | 0.15 |
| 2024-05-31 | -0.35 | 0.02 | 0.15 |
| 2024-02-29 | -0.27 | 0.02 | |
| 2023-11-30 | -0.36 | 0.02 | |
| 2023-08-31 | -0.41 | 0.55 | |
| 2023-05-31 | -0.15 | 0.55 | -0.40 |
| 2023-02-28 | -0.94 | 0.61 | |
| 2022-11-30 | -1.95 | 0.59 | |
| 2022-08-31 | -2.85 | -0.31 | 0.03 |
| 2022-05-31 | -3.73 | -0.33 | 0.42 |
| 2022-02-28 | -3.81 | -0.41 | 0.03 |
| 2021-11-30 | -5.33 | -0.38 | 4.98 |
| 2021-08-31 | -6.04 | 1.14 | 6.45 |
| 2021-05-31 | -5.83 | 1.23 | 7.76 |
| 2021-02-28 | -5.23 | 1.28 | 8.54 |
| 2020-11-30 | -2.84 | 1.08 | 4.43 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-05-31 | |||
| 2025-02-28 | |||
| 2024-11-30 | |||
| 2024-08-31 | |||
| 2024-05-31 | |||
| 2024-02-29 | |||
| 2023-11-30 | |||
| 2023-08-31 | |||
| 2023-05-31 | |||
| 2023-02-28 | |||
| 2022-11-30 | |||
| 2022-08-31 | |||
| 2022-05-31 | |||
| 2022-02-28 | |||
| 2021-11-30 | |||
| 2021-08-31 | |||
| 2021-05-31 | |||
| 2021-02-28 | |||
| 2020-11-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-05-31 | ||
| 2025-02-28 | ||
| 2024-11-30 | ||
| 2024-08-31 | ||
| 2024-05-31 | ||
| 2024-02-29 | ||
| 2023-11-30 | ||
| 2023-08-31 | ||
| 2023-05-31 | ||
| 2023-02-28 | ||
| 2022-11-30 | ||
| 2022-08-31 | ||
| 2022-05-31 | ||
| 2022-02-28 | ||
| 2021-11-30 | ||
| 2021-08-31 | ||
| 2021-05-31 | ||
| 2021-02-28 | ||
| 2020-11-30 |
Efektivitas Manajemen
- roa untuk Entheon Biomedical Corp. pada 2025 May 31 adalah -1.09.
- roe untuk Entheon Biomedical Corp. pada 2025 May 31 adalah -1.61.
- roic untuk Entheon Biomedical Corp. pada 2025 May 31 adalah -2.19.
- croic untuk Entheon Biomedical Corp. pada 2025 May 31 adalah -1.43.
- ocroic untuk Entheon Biomedical Corp. pada 2025 May 31 adalah -2.45.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-05-31 | -1.09 | -1.61 | -2.19 | -1.43 | -2.45 |
| 2025-02-28 | -0.77 | -0.97 | -1.34 | -0.67 | -1.35 |
| 2024-11-30 | -0.71 | -0.79 | -1.34 | -0.67 | -1.35 |
| 2024-08-31 | -0.49 | -0.58 | -1.16 | -1.00 | -1.10 |
| 2024-05-31 | -0.49 | -0.58 | -1.16 | -1.00 | -1.10 |
| 2024-02-29 | -0.42 | -0.54 | -1.16 | -1.00 | -1.10 |
| 2023-11-30 | -0.39 | -0.49 | -0.95 | -1.06 | -1.14 |
| 2023-08-31 | -0.91 | -0.92 | -15.59 | 0.34 | -1.12 |
| 2023-05-31 | -0.74 | -0.88 | -11.36 | 0.02 | -0.30 |
| 2023-02-28 | -0.81 | -0.92 | -12.97 | -0.63 | -1.86 |
| 2022-11-30 | -0.85 | -0.94 | -9.32 | -1.50 | -2.16 |
| 2022-08-31 | -0.44 | -0.45 | -0.66 | -0.45 | -0.45 |
| 2022-05-31 | -0.67 | -0.67 | -1.02 | -0.55 | -0.61 |
| 2022-02-28 | -0.65 | -0.66 | -1.07 | -0.57 | -0.56 |
| 2021-11-30 | -1.99 | -2.37 | -0.98 | -0.08 | -0.62 |
| 2021-08-31 | -5.06 | -5.17 | -1.03 | 0.15 | -0.60 |
| 2021-05-31 | -65.31 | -211.95 | -0.90 | 0.32 | -0.58 |
| 2021-02-28 | -32.01 | -103.89 | -1.17 | 0.71 | -0.76 |
| 2020-11-30 | -32.01 | -103.89 | -1.17 | 0.71 | -0.76 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-05-31 | |||
| 2025-02-28 | |||
| 2024-11-30 | |||
| 2024-08-31 | 1.00 | -2.14 | -2.17 |
| 2024-05-31 | 1.00 | -2.14 | -2.17 |
| 2024-02-29 | 1.00 | -2.14 | -2.17 |
| 2023-11-30 | 1.00 | -1.20 | -1.25 |
| 2023-08-31 | 1.00 | -16.38 | -1.27 |
| 2023-05-31 | 1.00 | -12.53 | -2.36 |
| 2023-02-28 | 0.94 | -21.79 | -7.06 |
| 2022-11-30 | 0.90 | -44.92 | -18.98 |
| 2022-08-31 | 0.82 | -43.30 | -60.27 |
| 2022-05-31 | 0.38 | -163.68 | -175.05 |
| 2022-02-28 | 0.40 | -257.43 | -254.71 |
| 2021-11-30 | 0.42 | -410.09 | -420.22 |
| 2021-08-31 | 0.51 | -1,401.20 | -1,021.86 |
| 2021-05-31 | 1.00 | -6,135.01 | -4,250.77 |
| 2021-02-28 | |||
| 2020-11-30 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
